Chronic lymphocytic leukemia cell line and its use for producing an antibody

Details for Australian Patent Application No. 2002246632 (hide)

Owner Alexion Pharmaceuticals, Inc

Inventors Bowdish, Katherine, S.; Mcwhirter, John

Agent Freehills

Pub. Number AU-B-2002246632

PCT Pub. Number WO2002/059280

Priority 60/254,113 08.12.00 US

Filing date 10 December 2001

Wipo publication date 6 August 2002

Acceptance publication date 5 April 2007

International Classifications

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/08 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-B-2002246632

5 April 2007 Application Accepted

  Published as AU-B-2002246632

16 August 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002246633-Method of diagnosing and treating cartilage disorders

2002246631-HLA-DR2 BINDING PEPTIDES